3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
22 23 0 0 0 0 0 0 0999 V2000
-2.7548 -1.9212 -0.5156 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6492 -0.1033 0.5146 O 0 0 0 0 0 0 0 0 0 0 0 0
0.2238 1.6461 -0.0845 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3259 -1.0731 0.0698 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2218 0.7467 -0.0319 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9435 -0.6304 0.0464 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0389 1.1829 -0.0600 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3098 -0.1574 0.0159 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5488 1.1693 -0.0542 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0024 -1.5336 0.0996 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1259 2.2004 -0.1207 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6013 0.2571 -0.0005 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3268 -1.1002 0.0767 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6638 -0.6832 0.0444 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7785 2.2313 -0.1146 H 1 0 0 0 0 0 0 0 0 0 0 0
1.8015 -2.6014 0.1604 H 1 0 0 0 0 0 0 0 0 0 0 0
-2.6691 2.2468 0.8281 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.8209 1.9894 -0.9396 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.7082 3.1968 -0.3041 H 0 0 0 0 0 0 0 0 0 0 0 0
4.6285 0.6080 -0.0191 H 1 0 0 0 0 0 0 0 0 0 0 0
4.1374 -1.8212 0.1191 H 1 0 0 0 0 0 0 0 0 0 0 0
-3.6730 -2.2659 -0.4911 H 0 0 0 0 0 0 0 0 0 0 0 0
1 14 1 0 0 0 0
1 22 1 0 0 0 0
2 14 2 0 0 0 0
3 5 1 0 0 0 0
3 7 2 0 0 0 0
4 6 1 0 0 0 0
4 8 2 0 0 0 0
5 6 1 0 0 0 0
5 9 2 0 0 0 0
6 10 2 0 0 0 0
7 8 1 0 0 0 0
7 11 1 0 0 0 0
8 14 1 0 0 0 0
9 12 1 0 0 0 0
9 15 1 0 0 0 0
10 13 1 0 0 0 0
10 16 1 0 0 0 0
11 17 1 0 0 0 0
11 18 1 0 0 0 0
11 19 1 0 0 0 0
12 13 2 0 0 0 0
12 20 1 0 0 0 0
13 21 1 0 0 0 0
M ISO 4 15 2 16 2 20 2 21 2
4. 国际命名与标识
4.1 IUPAC Name
5,6,7,8-tetradeuterio-3-methylquinoxaline-2-carboxylic acid
4.2 InChl
InChI=1S/C10H8N2O2/c1-6-9(10(13)14)12-8-5-3-2-4-7(8)11-6/h2-5H,1H3,(H,13,14)/i2D,3D,4D,5D
4.3 InChlKey
BJPNADFNSANIPF-QFFDRWTDSA-N
4.4 Canonical SMILES
CC1=NC2=CC=CC=C2N=C1C(=O)O
4.5 lsomeric SMILES
[2H]C1=C(C(=C2C(=C1[2H])N=C(C(=N2)C(=O)O)C)[2H])[2H]
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病